<--- Back to Details
First PageDocument Content
Oncology / Phosphoinositide 3-kinase / Phosphatidylinositol (3 / 4 / 5)-trisphosphate / AKT / PTEN / P110α / Medicine / Biology / Peripheral membrane proteins
Date: 2014-12-24 04:42:11
Oncology
Phosphoinositide 3-kinase
Phosphatidylinositol (3
4
5)-trisphosphate
AKT
PTEN
P110α
Medicine
Biology
Peripheral membrane proteins

Microsoft Word - cell6489mmc1.docx

Add to Reading List

Source URL: limlab.ucsf.edu

Download Document from Source Website

File Size: 103,20 KB

Share Document on Facebook

Similar Documents

Cell biology / Biology / Cell signaling / Cytokines / Signal transduction / Phospholipids / Chemotaxis / Phosphoinositide 3-kinase / Neutrophil / Phosphatidylinositol (3 / 4 / 5)-trisphosphate / Chemokine / Cyclic adenosine monophosphate

Cell Science at a Glance gradients. It is exhibited by a wide variety of cell types and involves distinct strategies that depend on the environmental conditions. For example, the migration of fibroblasts or keratinocytes

DocID: 1ropC - View Document

Biology / Cell biology / Biochemistry / Signal transduction / Cell signaling / Protein kinase B / Phosphatidylinositol (3 / 4 / 5)-trisphosphate / C-Met / T cell / G proteincoupled receptor / Phosphoinositide 3-kinase / Chemotaxis

doi:j.arr

DocID: 1qiOh - View Document

Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate–activated protein kinase and phosphatidylinositol-3 kinase pathways

DocID: 1mUud - View Document

Chairman’s Note Idelalisib the is first agent to target the phosphatidylinositol-3-kinase (PI3K) pathway and the second oral agent approved by the FDA, in July 2014, for treatment of relapsed/refractory chronic lymphoc

DocID: 1m4mv - View Document

Research Article PIK3CA Cooperates with Other Phosphatidylinositol 3¶-Kinase Pathway Mutations to Effect Oncogenic Transformation 1,3

DocID: 1kNe5 - View Document